Semantic search
Jump to navigation
Jump to search
Issue date | Site | Title | |
---|---|---|---|
ML23283A064 | 16 October 2023 | Summary of September 12, 2023, Public Meeting on Termination of NRC Recognition of the American Board of Radiology'S Certification Processes | |
ML23257A264 | 29 September 2023 | Summary of August 29, 2023, Public Meeting on Regulatory Basis for Part 35 Rulemaking on Rb-82 Generators, Emerging Technologies, and Other Medical Use of Byproduct Material | |
ML23257A212 | 14 September 2023 | August 31 2023 Summary of Non Public Meeting with Terumo | |
ML22090A096 | 31 March 2022 | Summary of February 22 2022 Closed Meeting Between U.S. NRC Staff and Check-Cap Ltd | |
ML22026A164 | 26 January 2022 | Summary of January 5, 2022 Closed Meeting with Check-Cap Regarding the C-Scan System | |
ML21005A436 | 16 March 2021 | December 8, 2020 Summary of U.S. Nuclear Regulatory Commission Public Meeting on Radiopharmaceutical Extravasations | |
ML21028A502 | 1 February 2021 | Summary of the January 5, 2021 Closed Meeting with Check-Cap Ltd. to Discuss the Applicability of 10 CFR 20.2003(b) for the Disposal of the C-Scan System to the Sanitary Sewer | |
ML20349A000 | 15 December 2020 | November 17 2020 Summary Public Meeting on COVID-19 Related Regulatory Relief for Medical, Industrial, and Academic Materials Licensees | |
ML19338C224 | 4 December 2019 | 11/4/2019 - Summary of Closed Meeting Between the U.S. Nuclear Regulatory Commission and Bayer Healthcare | |
ML19319A465 | 15 November 2019 | Summary of Nov 6, 2019, Pre-Submittal Public Meeting with Exubrion Therapeutics | |
ML19273A957 | 1 October 2019 | Meeting Summary of Public Teleconference with Euxbrion Therapeutics to Discuss Options for Continued Discussions on the Use of Sn-117m in Dogs for the Treatment of Osteoarthritis | |
ML19270E566 | 30 September 2019 | Summary of July 29, 2019, Public Meeting with Exubrion Therapeutics to Discuss Its Veterinary Uses of Sn-117m | |
ML19155A372 | 4 June 2019 | May 23, 2019 Summary of Public Meeting on the NRC Staff'S Draft Approaches Regarding Training and Experience Requirements for Radiopharmaceuticals | |
ML19144A256 | 24 May 2019 | Summary of Meeting on NRC Staff'S Draft Approaches Regarding Training and Experience Requirements for Radiopharmaceuticals | |
ML19058A320 | 27 February 2019 | January 22, 2019 Summary of Public Comment Meeting on the NRC Staff'S Evaluation of Training and Experience for Different Radiopharmaceuticals | |
ML19019A023 | 22 January 2019 | Summary of Meeting on the NRC Staff'S Evaluation of Training and Experience Requirements for Administering Radiopharmaceuticals | |
ML19002A614 | 9 January 2019 | Summary of Meeting on the Nrc'S Evaluation of Training and Experience Requirements for Administering Different Categories of Radiopharmaceuticals | |
ML18269A262 | 30 November 2018 | Solicitation of Topics for the 2019 Organization of Agreement States Annual Meeting | |
ML18333A384 | 30 November 2018 | November 14, 2018 Summary of Public Comment Meeting on Training and Experience Requirements for Certain Categories of Radiopharmaceuticals | |
ML18186A509 | 9 May 2018 | Invitation to the Nuclear Regulatory Commission'S Webinar on the Wyoming Agreement State Application (Talley) | |
ML18184A386 | 1 May 2018 | E-mail from Sandra Talley FW: Action - Outreach for Webinar | |
ML18184A372 | 19 April 2018 | E-mail from Sandra Talley FW: NRC Agreement State Webinar | |
ML18186A515 | 26 February 2018 | E-mail from Sandra Talley to Chris Einberg on Outreach Calls to Tribes on Wy Agreement State Webinar - Request for Consultation | |
ML050740507 | 6 October 2004 | LSN Indexing Schedule Announcement and Revisions to Document Status Field Contents |